David N Gill's Net Worth

$5.78 Million

Estimate Recalculated Jul 16, 2024 03:22PM EST

Who is David N Gill?

David N Gill has an estimated net worth of $5.78 Million. This is based on reported shares across multiple companies, which include ISOTIS INC, CTI MOLECULAR IMAGING INC, MELINTA THERAPEUTICS, INC. /NEW/, Y-mAbs Therapeutics, Inc., HISTOGENICS CORP, LEMAITRE VASCULAR INC, Evolus, Inc., Strongbridge Biopharma plc, STRATA Skin Sciences, Inc., EndoChoice Holdings, Inc., NxStage Medical, Inc., and IDLEAIRE TECHNOLOGIES CORP.

SEC CIK

David N Gill's CIK is 0001106519

Past Insider Trading and Trends

2016 was David N Gill's most active year for acquiring shares with 8 total transactions. David N Gill's most active month to acquire stocks was the month of May. 2004 was David N Gill's most active year for disposing of shares, totalling 8 transactions. David N Gill's most active month to dispose stocks was the month of October. 2004 saw David N Gill paying a total of $109,218.75 for 147,300 shares, this is the most they've acquired in one year. In 2005 David N Gill cashed out on 351,647 shares for a total of $2,037,700.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ISOTIS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 29
Form 3
—
0
—
—
0
No matching records found

CTI MOLECULAR IMAGING INC No price found

Senior Vice President and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-99.40K
$20.50
-$2,037,700.00
0
Apr 29 - May 5
Form 4
+11.64%
9.7K
$4.69
$45,468.75
93K
Jan 18
Form 4
+14.42%
10.5K
$4.69
$49,223.44
83.3K
Oct 18
Form 4
+21.33%
12.8K
$4.69
$59,995.31
72.8K
Oct 14
Form 4
∞
60K
—
—
60K
Oct 7
Form 4
-100.00%
-15.00K
$13.72
-$205,800.00
0
Jun 2
Form 4
-40.00%
-10.00K
$14.07
-$140,700.00
15K
May 11
Form 4
-35.90%
-14.00K
$16.49
-$230,889.40
25K
Mar 2
Form 4
-29.09%
-16.00K
$17.67
-$282,720.00
39K
Feb 17
Form 4
—
0
—
—
0
Nov 25
Form 4
-8.33%
-5.00K
$15.45
-$77,250.00
55K
Dec 15
Form 4
-24.09%
-19.04K
$15.38
-$292,764.00
60K
Dec 10 - Dec 11
No matching records found

MELINTA THERAPEUTICS, INC. /NEW/ No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
+500.00%
5K
$6.09
$30,450.00
6K
May 25
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
5K
$2.94
$14,720.00
5K
Jan 3
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Apr 2
Form 3
—
0
—
—
0
No matching records found

Y-mAbs Therapeutics, Inc. (YMAB) Snapshot price: $13.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+150.00%
3.5K
—
—
5.83K
Jun 11
Form 4
∞
2.33K
—
—
2.33K
Jun 8
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
$28.84
-$70,725.20
0
Scheduled
Jan 19
Form 4
—
0
$28.47
-$69,210.00
0
Scheduled
Nov 18
Form 4
—
0
$28.08
-$135,360.00
0
Scheduled
Nov 3
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 12
Form 3
—
0
—
—
0
No matching records found

HISTOGENICS CORP (OCGN) Snapshot price: $0.5148

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
+27.27%
3K
$1.81
$5,439.00
14K
Aug 16
Form 4
—
0
—
—
0
Jun 13
Form 4
+37.50%
3K
$1.68
$5,040.00
11K
May 16
Form 4
—
0
—
—
0
Dec 16
Form 4
+60.00%
3K
$1.65
$4,950.00
8K
Dec 15
Form 4
∞
5K
$1.92
$9,600.00
5K
Dec 9
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Feb 2
Form 3
—
0
—
—
0
No matching records found